Showing results (51-60 of 257) with videos related to

Sort By:
Pageof 26
British Journal of Cancer|August 23, 2025
Refining treatment strategies for non-small cell lung cancer lacking actionable mutations: insights from multi-omics studiesAndrea Rocca, Lucio Crinò, Luca Braga, et al.
Cancer Research|October 6, 2005
Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell functionNilay S Patel, Ji-Liang Li, Daniele Generali, et al.
Research and Reports in Urology|May 12, 2017
Enteric-coated and highly standardized cranberry extract reduces antibiotic and nonsteroidal anti-inflammatory drug use for urinary tract infections during radiotherapy for prostate carcinomaAlberto Bonetta, Giandomenico Roviello, Daniele Generali, et al.
The American Journal of Case Reports|August 15, 2017
Isolated Testicular Metastasis from Prostate CancerAlberto Bonetta, Daniele Generali, Silvia Paola Corona, et al.
The Journal of Rheumatology|July 26, 2002
Anti-Ku antibodies in connective tissue diseases: clinical and serological evaluation of 14 patientsFranco Franceschini, Ilaria Cavazzana, Daniele Generali, et al.
Cancers|June 24, 2022
Predictive and Prognostic Value of Non-Coding RNA in Breast CancerNavid Sobhani, Richard Chahwan, Raheleh Roudi, et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|June 16, 2018
PIK3CA mutation in gastric cancer and the role of microsatellite instability status in mutations of exons 9 and 20 of the PIK3CA geneKarol Polom, Daniele Marrelli, Giandomenico Roviello, et al.
Cancer Letters|January 23, 2016
Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancerGiandomenico Roviello, Andrea Ravelli, Karol Polom, et al.
Cancer Immunology, Immunotherapy : CII|August 29, 2023
Cancer management during the COVID-19 world pandemicNavid Sobhani, Giuseppina Mondani, Giandomenico Roviello, et al.
Cancer Research|May 7, 2009
The role of ATF4 stabilization and autophagy in resistance of breast cancer cells treated with BortezomibManuela Milani, Tomasz Rzymski, Howard R Mellor, et al.
Pageof 26